EOSINOPHILIC ASTHMA
Clinical trials for EOSINOPHILIC ASTHMA explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC ASTHMA trials appear
Sign up with your email to follow new studies for EOSINOPHILIC ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New oral drug shows promise for Hard-to-Control asthma
Disease control OngoingThis study tests an oral medication called dexpramipexole for people with eosinophilic asthma that is not well controlled by current treatments. About 600 participants will take the drug or a placebo daily for 24 weeks to see if it improves lung function, asthma control, and qual…
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Spit test could predict drug response in rare lung disease
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks for proteins in blood, saliva, and sputum that can show organ damage and predict how well patients with EGPA (a rare inflammatory disease) or severe asthma respond to the drug mepolizumab. Researchers will analyze samples from 90 participants before and after sta…
Matched conditions: EOSINOPHILIC ASTHMA
Phase: PHASE4 • Sponsor: Azienda Ospedaliero Universitaria di Cagliari • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC